Enorama Pharma AB (publ) (STO: ERMA)

Enorama Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	291	85	188	546	444	610
Market Cap Growth	193.13%	-54.73%	-65.59%	23.12%	-27.27%	36.61%
Enterprise Value	274	45	147	495	373	549
Last Close Price	4.81	1.10	3.53	12.04	10.75	14.78
PE Ratio	-	-2.73	-6.56	-32.43	-31.63	897.83
PS Ratio	33.61	1.13	2.07	6.56	4.81	6.64
PB Ratio	7.51	0.53	1.29	4.27	3.89	4.83
P/FCF Ratio	-27.00	-7.11	51.56	-126.61	22.49	-775.39
P/OCF Ratio	-30.39	-7.91	47.83	-365.99	20.37	-1279.31
EV/Sales Ratio	46.66	0.60	1.61	5.95	4.03	5.98
EV/EBITDA Ratio	-14.60	-2.00	-9.27	-53.23	-85.22	291.26
EV/EBIT Ratio	-12.53	-1.70	-7.33	-43.10	-64.31	843.82
EV/FCF Ratio	-25.24	-3.76	40.24	-114.79	18.88	-698.00
Debt / Equity Ratio	0.15	0.14	0.22	0.06	0.06	0.01
Debt / EBITDA Ratio	-	-	-	-	-	0.30
Debt / FCF Ratio	-2.08	-1.83	8.97	-1.76	0.34	-1.36
Asset Turnover	0.36	0.35	0.40	0.42	0.59	0.58
Inventory Turnover	66.71	81.33	60.49	24.72	-	-
Quick Ratio	1.96	1.96	1.48	1.24	2.76	3.34
Current Ratio	1.97	2.05	1.57	1.30	2.90	3.40
Return on Equity (ROE)	-13.11%	-17.28%	-16.21%	-11.11%	-10.12%	0.81%
Return on Assets (ROA)	-5.95%	-7.77%	-5.51%	-3.65%	-2.32%	0.26%
Return on Capital (ROIC)	-7.16%	-9.18%	-7.95%	-5.60%	-2.91%	0.32%
Earnings Yield	-20.99%	-31.02%	-11.82%	-2.46%	-2.76%	0.10%
FCF Yield	-3.70%	-14.07%	1.94%	-0.79%	4.45%	-0.13%
Buyback Yield / Dilution	-7.95%	-58.74%	-14.02%	-0.56%	0.18%	-0.18%
Total Shareholder Return	-7.95%	-58.74%	-14.02%	-0.56%	0.18%	-0.18%

Source: S&P Capital IQ. Standard template. Financial Sources.